XML 81 R5.htm IDEA: XBRL DOCUMENT v3.20.1
CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY - EUR (€)
€ in Thousands
Share capital
Share premium
Accumulated losses
Other reserves
Total equity attributable to owners of the parent
Total
Equity at beginning of period at Dec. 31, 2016 € 2,012 € 126,358 € (72,492) € 7,496 € 63,374 € 63,374
Total comprehensive loss of the period     (28,076)   (28,076) (28,076)
Share-based payment       4,268 4,268 4,268
Issue of new shares 1,185 326,515     327,700 327,700
Transaction costs for equity issue (restated)   (23,015)     (23,015) (23,015)
Exercise of stock options 19 660     679 679
Equity at end of period at Dec. 31, 2017 3,216 430,518 (100,568) 11,764 344,931 344,931
Total comprehensive loss of the period           (66,641)
Equity at end of period at Dec. 31, 2018 3,597 673,454 (169,603) 30,947 538,395 538,395
Equity at beginning of period at Jan. 01, 2018 3,216 430,518 (102,962) 11,764 342,536 342,536
Total comprehensive loss of the period     (66,641)   (66,641) (66,641)
Share-based payment       19,183 19,183 19,183
Issue of new shares 347 255,374     255,721 255,721
Transaction costs for equity issue (restated)   (14,655)     (14,655) (14,655)
Exercise of stock options 34 2,217     2,251 2,251
Equity at end of period at Dec. 31, 2018 3,597 673,454 (169,603) 30,947 538,395 538,395
Adoption of IFRS 15 (modified retrospective approach)     (2,395)   (2,395) (2,395)
Total comprehensive loss of the period     (162,965)   (162,965) (162,965)
Share-based payment       39,552 39,552 39,552
Issue of new shares 637 678,299     678,936 678,936
Transaction costs for equity issue (restated)   (22,999)     (22,999) (22,999)
Accounting treatment of the share subscription agreement   (24,948)     (24,948) (24,948)
Exercise of stock options 42 4,733     4,775 4,775
Equity at end of period at Dec. 31, 2019 € 4,276 € 1,308,539 € (332,568) € 70,499 € 1,050,746 € 1,050,746